Analytical Data
-
基因名
C2
- Application
-
别名
C2；C2 domain-containing Protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P07910
-
表达区间
1-293aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMASNVTNKTDPRSMNSRVFIGNLNTLVVKK SDVEAIFSKYGKIVGCSVHKGFAFVQYVNERNARAAVAGEDGRMIAGQVL DINLAAEPKVNRGKAGVKRSAAEMYGSSFDLDYDFQRDYYDRMYSYPARV PPPPPIARAVVPSKRQRVSGNTSRRGKSGFNSKSGQRGSSKSGKLKGDDL QAIKKELTQIKQKVDSLLENLEKIEKEQSKQAVEMKNDKSEEEQSSSSVK KDETNVKMESEGGADDSAEEGDLLDDDDNEDRGDDQLELIKDDEKEAEEG EDDRDSANGEDDS
-
分子量
35 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C2 recombinant proteins have gained significant attention in biomedical research due to their diverse applications in drug development, vaccine production, and therapeutic protein engineering. The C2 domain, originally identified in certain bacterial toxins and mammalian proteins, plays a crucial role in calcium-dependent membrane interactions and cellular signaling. Researchers have harnessed the unique properties of the C2 domain to create recombinant proteins that can effectively target specific biomolecules or pathways. This is particularly valuable in the development of targeted therapies for various diseases, including cancer and autoimmune disorders. Additionally, C2 recombinant proteins are being explored for their potential in enhancing vaccine efficacy by serving as adjuvants, facilitating stronger immune responses. As techniques in genetic engineering and protein expression continue to advance, the generation of C2 recombinant proteins with enhanced functionality and specificity is becoming increasingly feasible. This progression opens new avenues for innovative therapeutic strategies and diagnostics, marking a significant step forward in the field of molecular biology and medicine.
